<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01889862</url>
  </required_header>
  <id_info>
    <org_study_id>165-302</org_study_id>
    <nct_id>NCT01889862</nct_id>
  </id_info>
  <brief_title>Phase 3 Study to Evaluate the Efficacy &amp; Safety of Self-Administered Injections of BMN165 by Adults With PKU</brief_title>
  <acronym>Prism-2</acronym>
  <official_title>A Four-Part, Phase 3, Randomized, Double-Blind, Placebo- Controlled, Four-Arm, Discontinuation Study to Evaluate the Efficacy and Safety of Subcutaneous Injections of BMN 165 Self-Administered by Adults With Phenylketonuria (PKU)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>BioMarin Pharmaceutical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>BioMarin Pharmaceutical</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The BMN 165 clinical development program has been designed to demonstrate the safety and&#xD;
      efficacy of BMN 165 in reducing blood Phe concentrations in adults with PKU.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      165-302 is a Phase 3, 4 Part, Randomized, Double-Blind, Placebo-Controlled, Discontinuation&#xD;
      Study to Evaluate the Efficacy and Safety of Self Administered Subcutaneous Injections of BMN&#xD;
      165 by Adults With PKU.&#xD;
&#xD;
      This study is open only to adults who have been exposed to BMN165 in a previous study.&#xD;
&#xD;
      Study BMN 165-302 is a four-Part, Phase 3 study.&#xD;
&#xD;
        -  Part 1: Open-label period&#xD;
&#xD;
        -  Part 2: A Randomized, double-blind, placebo-controlled period of 8 weeks&#xD;
&#xD;
        -  Part 3: Two sub-Parts to Part 3:- Part 3A - BMN 165 administered using vial and syringe&#xD;
           during this open label period. Part 3B - BMN 165 administered using prefilled syringe&#xD;
           during this open-label period.&#xD;
&#xD;
        -  Part 4: A long-term, open-label extension period.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 29, 2013</start_date>
  <completion_date type="Actual">February 5, 2019</completion_date>
  <primary_completion_date type="Actual">January 13, 2016</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change From Baseline in the Blood Plasma Phenylalanine (Phe) Concentration at Part 2</measure>
    <time_frame>At Part 2 baseline and change from baseline at Part 2 week 8</time_frame>
    <description>Blood phe concentration in subjects previously exposed to BMN165 who were administered BMN165 20 or 40 mg/day compared with those who were administered a matching placebo.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in the Cognitive and Mood Symptoms Measured by ADHD Rating Scale (RS)-IV Inattention Subscale at Part 2</measure>
    <time_frame>At Part 2 baseline and change from baseline at Part 2 week 8</time_frame>
    <description>Attention deficit hyperactivity disorder rating scale IV (ADHD RS-IV) is investigator-rated, 9-item, inattention subscale score ranges from 0 to 27, with higher scores indicative of a greater degree of impairment and a baseline score &gt;9 indicative of a presence of symptoms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in the Blood Plasma Phenylalanine (Phe) Concentration at Part 4</measure>
    <time_frame>At Part 4 week 57, 105, 161, 209 and 249</time_frame>
    <description>The long term effect of multiple dose levels of BMN165 on blood phe concentration in subjects who are administered BMN165 using pre-filled syringes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in the Cognitive and Mood Symptoms Measured by PKU POMS TMD at Part 2</measure>
    <time_frame>At Part 2 baseline and change from baseline at Part 2 week 8</time_frame>
    <description>Phenylketonuria (PKU) Total Mood Disturbance (TMD) Profile of Mood States (POMS)&#xD;
PKU POMS TMD is self-rated, each item in the tool is rated using a five-point Likert scale: 0 (not at all), 1 (a little), 2 (moderately), 3 (quite a bit), and 4 (extremely).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in the Cognitive and Mood Symptoms Measured by PKU POMS Confusion Subscale at Part 2</measure>
    <time_frame>At Part 2 baseline and change from baseline at Part 2 week 8</time_frame>
    <description>PKU POMS confusion mood domain (referred to as the confusion subscale) is self-rated, each item in the tool is rated using a five-point Likert scale: 0 (not at all), 1 (a little), 2 (moderately), 3 (quite a bit), and 4 (extremely).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change From Baseline in the Cognitive and Mood Symptoms Measured by POMS TMD at Part 2</measure>
    <time_frame>At Part 2 baseline and change from baseline at Part 2 week 8</time_frame>
    <description>Full-length POMS TMD is self-rated, each item in the tool is rated using a five-point Likert scale: 0 (not at all), 1 (a little), 2 (moderately), 3 (quite a bit), and 4 (extremely).</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">215</enrollment>
  <condition>Phenylketonuria (PKU)</condition>
  <arm_group>
    <arm_group_label>BMN165 20mg/day</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>BMN165 20mg/day self-administered daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>20 mg/day Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>20 mg/day Placebo self-administered daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>BMN165 40mg/day</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>BMN165 40mg/day self-administered daily</description>
  </arm_group>
  <arm_group>
    <arm_group_label>40 mg/day Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>40 mg/day Placebo self-administered daily</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>BMN165 20mg/day</intervention_name>
    <description>BMN165 20mg/day self-administered daily</description>
    <arm_group_label>BMN165 20mg/day</arm_group_label>
    <other_name>PEG-PAL</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>BMN165 40mg/day</intervention_name>
    <description>BMN165 40mg/day self-administered daily</description>
    <arm_group_label>BMN165 40mg/day</arm_group_label>
    <other_name>PEG-PAL</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Non-drug placebo, self-administered daily</description>
    <arm_group_label>20 mg/day Placebo</arm_group_label>
    <arm_group_label>40 mg/day Placebo</arm_group_label>
    <other_name>Dextran 40</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        INCLUSION CRITERIA&#xD;
&#xD;
        Individuals eligible to participate in this study must meet all of the following criteria:&#xD;
&#xD;
          -  Have completed a prior BMN 165 study (PAL-003, 165-205, or 165-301) prior to screening&#xD;
&#xD;
          -  Have had a stable BMN 165 dose regimen for at least 14 days prior to screening&#xD;
&#xD;
          -  Are at least 18 y/o and no older than 70 y/o at screening&#xD;
&#xD;
               -  Subjects who are &lt; 18 y/o and are already enrolled into Study 165-301 under&#xD;
                  Amendment #1 (10JAN2014) may enroll into this study&#xD;
&#xD;
          -  Has identified a person who is &gt; 18 y/o who has the neurocognitive and linguistic&#xD;
             capacities to comprehend and complete the Profile of Mood States (POMS)-Observer rated&#xD;
             scale&#xD;
&#xD;
          -  Has identified a competent person(s) &gt; 18 y/o who can observe the subject during study&#xD;
             drug administration at certain points in the study&#xD;
&#xD;
               -  A home healthcare nurse may perform the study drug observations&#xD;
&#xD;
          -  Are willing and able to provide written, signed informed consent after the nature of&#xD;
             the study has been explained and prior to any research-related procedures; for minors,&#xD;
             parent or guardian provides written consent and assent may be requested&#xD;
&#xD;
          -  Are willing and able to comply with all study procedures&#xD;
&#xD;
          -  For females of childbearing potential, a negative pregnancy test at screening and&#xD;
             willing to have additional pregnancy tests during the study&#xD;
&#xD;
          -  If sexually active, willing to use two acceptable methods of contraception during and&#xD;
             for 4 weeks after the study&#xD;
&#xD;
               -  Males post vasectomy for 2 years with no known pregnancies do not need to use any&#xD;
                  other forms of contraception during the study.&#xD;
&#xD;
               -  Females who have been in menopause for at least 2 years, have had a tubal&#xD;
                  ligation at least 1 year prior to screening, or have had a total hysterectomy do&#xD;
                  not need to use any other forms of contraception during the study.&#xD;
&#xD;
          -  Have received documented approval from a study dietitian confirming that the subject&#xD;
             is capable of maintaining their diet&#xD;
&#xD;
          -  Have neurocognitive and linguistic capacities to comprehend and answer investigator's&#xD;
             prompts for the Attention Deficit Hyperactivity Disorder Rating Scale (ADHD-RS)&#xD;
             Investigator rated instrument and to complete the POMS-Subject rated scale&#xD;
&#xD;
          -  If applicable, maintained stable dose of medication for Attention Deficit&#xD;
             Hyperactivity Disorder (ADHD), depression, anxiety, or other psychiatric disorder ≥8&#xD;
             weeks prior to enrollment and willing to maintain stable dose throughout study unless&#xD;
             a change is medically indicated&#xD;
&#xD;
          -  General good health, as evidenced by physical examination, clinical laboratory&#xD;
             evaluations, and ECG tests at screening&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
        Individuals who meet any of the following exclusion criteria will not be eligible to&#xD;
        participate in the study:&#xD;
&#xD;
          -  Use of any investigational product (except BMN 165) or investigational medical device&#xD;
             within 30 days prior to screening or requirement for any investigational agent prior&#xD;
             to completion of all scheduled study assessments&#xD;
&#xD;
          -  Use of any medication (except BMN 165) intended to treat PKU, including the use of&#xD;
             large neutral amino acids, within 2 days prior to the administration of study drug&#xD;
&#xD;
          -  Have known hypersensitivity to Dextran® or components of Dextran&#xD;
&#xD;
          -  Use or planned use of any injectable drugs containing PEG (except for BMN 165),&#xD;
             including medroxyprogesterone injection, within 3 months prior to screening and during&#xD;
             study participation&#xD;
&#xD;
          -  Current use of levodopa&#xD;
&#xD;
          -  A positive test for HIV antibody, hepatitis B surface antigen, or hepatitis C antibody&#xD;
&#xD;
          -  A history of organ transplantation or taking chronic immunosuppressive therapy&#xD;
&#xD;
          -  A history of substance abuse in the past 12 months or current alcohol or drug abuse&#xD;
&#xD;
          -  Current participation in the Kuvan registry study (PKUDOS). Patients may discontinue&#xD;
             the PKUDOS registry trial to allow enrollment in this study&#xD;
&#xD;
          -  Pregnant or breastfeeding at screening or planning to become pregnant (self or&#xD;
             partner) or breastfeed at any time during the study&#xD;
&#xD;
          -  Concurrent disease or condition that would interfere with study participation or&#xD;
             safety.&#xD;
&#xD;
          -  Major surgery planned during the study period&#xD;
&#xD;
          -  Any condition that in the view of the investigator, places the subject at high risk of&#xD;
             poor treatment compliance or terminating early from the study&#xD;
&#xD;
          -  Alanine aminotransferase (ALT) concentration at least 2x the upper limit of normal&#xD;
&#xD;
          -  Creatinine at least 1.5x the upper limit of normal&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Clinical Trial Specialist</last_name>
    <role>Study Director</role>
    <affiliation>BioMarin Pharmaceutical</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of California, San Diego Clinical and Translational Research Institute</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92093</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UCSF Benioff Children's Hospital Oakland</name>
      <address>
        <city>Oakland</city>
        <state>California</state>
        <zip>94609</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital Colorado</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Florida Clinical Research Center</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of South Florida</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33606</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Emory Universty, Department of Human Genetics, Division of Medical Genetics</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ann and Robert H Lurie Children's Hospital of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Indiana CTSI Clinical Research Center</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Kentucky Medical Center</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40536</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Louisville, Kosair Charities Pediatric Clinical Research Unit</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Boston Children's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wayne State University Clinical Research Center at the Mott Center</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Missouri Health Center</name>
      <address>
        <city>Columbia</city>
        <state>Missouri</state>
        <zip>65212</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Washington University Center for Applied Research Sciences</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Nebraska Medical Center</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68198</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cooper Health Systems</name>
      <address>
        <city>Camden</city>
        <state>New Jersey</state>
        <zip>08103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Atlantic Health System - Morristown Medical Center</name>
      <address>
        <city>Morristown</city>
        <state>New Jersey</state>
        <zip>07960</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Albany Medical Center</name>
      <address>
        <city>Albany</city>
        <state>New York</state>
        <zip>12208</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Icahn School of Medicine at Mount Sinai Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospitals Case Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Oklahoma Health Sciences Center</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oregon Health and Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Christopher's Hospital for Children</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19134</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15224</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vanderbilt Children's Hospital</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Texas Houston Medical School</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Utah Hospital</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84108</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Washinton</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical College of Wisconsin</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.pku.com</url>
    <description>BioMarin sponsored PKU educational/community website</description>
  </link>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>June 18, 2013</study_first_submitted>
  <study_first_submitted_qc>June 26, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 1, 2013</study_first_posted>
  <results_first_submitted>June 22, 2018</results_first_submitted>
  <results_first_submitted_qc>June 18, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">July 12, 2019</results_first_posted>
  <disposition_first_submitted>December 22, 2017</disposition_first_submitted>
  <disposition_first_submitted_qc>December 22, 2017</disposition_first_submitted_qc>
  <disposition_first_posted type="Actual">December 27, 2017</disposition_first_posted>
  <last_update_submitted>April 29, 2021</last_update_submitted>
  <last_update_submitted_qc>April 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>PKU</keyword>
  <keyword>PEG-PAL</keyword>
  <keyword>Prism</keyword>
  <keyword>BioMarin</keyword>
  <keyword>rAvPAL-PEG</keyword>
  <keyword>BMN165</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Phenylketonurias</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dextrans</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>This was a multicenter study, conducted in 29 study centers of United States.</recruitment_details>
      <pre_assignment_details>A total of 51 out of 215 subjects entered Part 4 directly from 165-301, as they did not receive target dose of 20 or 40 mg/day in 165-301.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>BMN165 20mg/Day</title>
          <description>BMN165 20mg/day subcutaneous injection administered using vial and syringe in Part 1, 2 and 3A.&#xD;
BMN165 20mg/day subcutaneous injection administered using a prefilled syringe in Part 3B.</description>
        </group>
        <group group_id="P2">
          <title>Placebo 20mg/Day</title>
          <description>Matching placebo 20mg/day subcutaneous injection administered using vial and syringe in Part 2.</description>
        </group>
        <group group_id="P3">
          <title>BMN165 40mg/Day</title>
          <description>BMN165 40mg/day subcutaneous injection administered using vial and syringe in Part 1, 2 and 3A.&#xD;
BMN165 40mg/day subcutaneous injection administered using a prefilled syringe in Part 3B.</description>
        </group>
        <group group_id="P4">
          <title>Placebo 40mg/Day</title>
          <description>Matching placebo 40mg/day subcutaneous injection administered using vial and syringe in Part 2.</description>
        </group>
        <group group_id="P5">
          <title>BMN165</title>
          <description>Up to 60mg/day BMN165 subcutaneous injection administered using a prefilled syringe in Part 4.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Part 1 (Up to 13 Weeks)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="86"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="78"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="74">Out of 164, total 12 subjects have not completed Part 1.</participants>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="78"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Part 2 (8 Weeks)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="34">Subjects ≥20% reduction in blood Phe from naïve baseline levels are randomized in Part 2.</participants>
                <participants group_id="P2" count="15">Subjects ≥20% reduction in blood Phe from naïve baseline levels are randomized in Part 2.</participants>
                <participants group_id="P3" count="32">Subjects ≥20% reduction in blood Phe from naïve baseline levels are randomized in Part 2.</participants>
                <participants group_id="P4" count="14">Subjects ≥20% reduction in blood Phe from naïve baseline levels are randomized in Part 2.</participants>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Per Amendment #2 of the Protocol</title>
              <participants_list>
                <participants group_id="P1" count="29"/>
                <participants group_id="P2" count="14"/>
                <participants group_id="P3" count="29"/>
                <participants group_id="P4" count="14"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
                <participants group_id="P2" count="15"/>
                <participants group_id="P3" count="31"/>
                <participants group_id="P4" count="14"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Part 3A/B (6 Week)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="48">Subjects switch from placebo to active 20mg/kg.</participants>
                <participants group_id="P2" count="0">Subjects switch from placebo to active 20mg/kg.</participants>
                <participants group_id="P3" count="41">Subjects switch from placebo to active 40mg/kg.</participants>
                <participants group_id="P4" count="0">Subjects switch from placebo to active 40mg/kg.</participants>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Per Amendment #2 of the Protocol</title>
              <participants_list>
                <participants group_id="P1" count="34"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="26"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="48"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="41"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Part 4 (Up to 274 Weeks)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="0">51, 57, 5 and 89 subjects from 165-301, 165-302 Part 1, 2 &amp; 3 entered 165-302 Part 4 respectively.</participants>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0">51, 57, 5 and 89 subjects from 165-301, 165-302 Part 1, 2 &amp; 3 entered 165-302 Part 4 respectively.</participants>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="202">Total of 202 subjects from 165-301, Part 1, 2, 3 entered Part 4 to receive dose of up to 60mg/kg.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="172"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="30"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Subject withdrew consent</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="14"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol deviations</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>All Subjects consists of subjects participated in 165-302 Part 1, 2, 3 and 4.</population>
      <group_list>
        <group group_id="B1">
          <title>All Subjects</title>
          <description>BMN165 20mg/Day:&#xD;
BMN165 20mg/day subcutaneous injection administered using vial and syringe in Part 1, 2 and 3A.&#xD;
BMN165 20mg/day subcutaneous injection administered using a prefilled syringe in Part 3B.&#xD;
Placebo 20mg/Day:&#xD;
Matching placebo 20mg/day subcutaneous injection administered using vial and syringe in Part 2.&#xD;
BMN165 40mg/Day:&#xD;
BMN165 40mg/day subcutaneous injection administered using vial and syringe in Part 1, 2 and 3A.&#xD;
BMN165 40mg/day subcutaneous injection administered using a prefilled syringe in Part 3B.&#xD;
Placebo 40mg/Day:&#xD;
Matching placebo 40mg/day subcutaneous injection administered using vial and syringe in Part 2.&#xD;
BMN165:&#xD;
Up to 60mg/day BMN165 subcutaneous injection administered using a prefilled syringe in Part 4.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="215"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>yrs</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29.22" spread="8.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>16 - &lt;18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>18 - &lt;66 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="204"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="105"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="110"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="211"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black/African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in the Blood Plasma Phenylalanine (Phe) Concentration at Part 2</title>
        <description>Blood phe concentration in subjects previously exposed to BMN165 who were administered BMN165 20 or 40 mg/day compared with those who were administered a matching placebo.</description>
        <time_frame>At Part 2 baseline and change from baseline at Part 2 week 8</time_frame>
        <population>Modified Intent-to-Treat (mITT) population consists of all subjects who reached the randomized dose of 20mg/day or 40mg/day and were randomized into Part 2 with a mean blood Phe reduction of ≥20% (using the last two consecutive blood Phe assessments of Part 1) from the baseline of 165-301 (or the Phase 2 study in which they initiated BMN165).</population>
        <group_list>
          <group group_id="O1">
            <title>BMN165 20mg/Day</title>
            <description>BMN165 20mg/day subcutaneous injection administered using vial and syringe in Part 1, 2 and 3A.&#xD;
BMN165 20mg/day subcutaneous injection administered using a prefilled syringe in Part 3B.</description>
          </group>
          <group group_id="O2">
            <title>Placebo 20mg/Day</title>
            <description>Matching placebo 20mg/day subcutaneous injection administered using vial and syringe in Part 2.</description>
          </group>
          <group group_id="O3">
            <title>BMN165 40mg/Day</title>
            <description>BMN165 40mg/day subcutaneous injection administered using vial and syringe in Part 1, 2 and 3A.&#xD;
BMN165 40mg/day subcutaneous injection administered using a prefilled syringe in Part 3B.</description>
          </group>
          <group group_id="O4">
            <title>Placebo 40mg/Day</title>
            <description>Matching placebo 40mg/day subcutaneous injection administered using vial and syringe in Part 2.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in the Blood Plasma Phenylalanine (Phe) Concentration at Part 2</title>
          <description>Blood phe concentration in subjects previously exposed to BMN165 who were administered BMN165 20 or 40 mg/day compared with those who were administered a matching placebo.</description>
          <population>Modified Intent-to-Treat (mITT) population consists of all subjects who reached the randomized dose of 20mg/day or 40mg/day and were randomized into Part 2 with a mean blood Phe reduction of ≥20% (using the last two consecutive blood Phe assessments of Part 1) from the baseline of 165-301 (or the Phase 2 study in which they initiated BMN165).</population>
          <units>µmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="14"/>
                <count group_id="O3" value="29"/>
                <count group_id="O4" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Part 2 Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="596.8" spread="582.75"/>
                    <measurement group_id="O2" value="563.9" spread="504.62"/>
                    <measurement group_id="O3" value="410.9" spread="439.95"/>
                    <measurement group_id="O4" value="508.2" spread="363.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from Baseline Part 2 Week 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-65.9" spread="192.02"/>
                    <measurement group_id="O2" value="996.4" spread="555.00"/>
                    <measurement group_id="O3" value="114.1" spread="332.40"/>
                    <measurement group_id="O4" value="599.0" spread="507.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Change in blood Phe concentration during Part 2 in subjects previously exposed to BMN165 who self administer BMN165 20mg/day compared with those who self administer matching placebo.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>Based on Mixed-Effect Model Repeated Measure (MMRM) model with change from baseline as the response variable, and treatment, visit and treatment by visit interaction and baseline blood phe concentration as factors.</p_value_desc>
            <method>ANCOVA</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-973.02</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1204.19</ci_lower_limit>
            <ci_upper_limit>-741.85</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>Change in blood Phe concentration during Part 2 in subjects previously exposed to BMN165 who self administer BMN165 40mg/day compared with those who self administer matching placebo.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>Based on Mixed-Effect Model Repeated Measure (MMRM) model with change from baseline as the response variable, and treatment, visit and treatment by visit interaction and baseline blood phe concentration as factors.</p_value_desc>
            <method>ANCOVA</method>
            <param_type>Mean Difference (Net)</param_type>
            <param_value>-588.50</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-830.07</ci_lower_limit>
            <ci_upper_limit>-346.94</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in the Cognitive and Mood Symptoms Measured by ADHD Rating Scale (RS)-IV Inattention Subscale at Part 2</title>
        <description>Attention deficit hyperactivity disorder rating scale IV (ADHD RS-IV) is investigator-rated, 9-item, inattention subscale score ranges from 0 to 27, with higher scores indicative of a greater degree of impairment and a baseline score &gt;9 indicative of a presence of symptoms.</description>
        <time_frame>At Part 2 baseline and change from baseline at Part 2 week 8</time_frame>
        <population>mITT population</population>
        <group_list>
          <group group_id="O1">
            <title>BMN165 20mg/Day</title>
            <description>BMN165 20mg/day subcutaneous injection administered using vial and syringe in Part 1, 2 and 3A.&#xD;
BMN165 20mg/day subcutaneous injection administered using a prefilled syringe in Part 3B.</description>
          </group>
          <group group_id="O2">
            <title>Placebo 20mg/Day</title>
            <description>Matching placebo 20mg/day subcutaneous injection administered using vial and syringe in Part 2.</description>
          </group>
          <group group_id="O3">
            <title>BMN165 40mg/Day</title>
            <description>BMN165 40mg/day subcutaneous injection administered using vial and syringe in Part 1, 2 and 3A.&#xD;
BMN165 40mg/day subcutaneous injection administered using a prefilled syringe in Part 3B.</description>
          </group>
          <group group_id="O4">
            <title>Placebo 40mg/Day</title>
            <description>Matching placebo 40mg/day subcutaneous injection administered using vial and syringe in Part 2.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in the Cognitive and Mood Symptoms Measured by ADHD Rating Scale (RS)-IV Inattention Subscale at Part 2</title>
          <description>Attention deficit hyperactivity disorder rating scale IV (ADHD RS-IV) is investigator-rated, 9-item, inattention subscale score ranges from 0 to 27, with higher scores indicative of a greater degree of impairment and a baseline score &gt;9 indicative of a presence of symptoms.</description>
          <population>mITT population</population>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="14"/>
                <count group_id="O3" value="29"/>
                <count group_id="O4" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.9" spread="4.70"/>
                    <measurement group_id="O2" value="5.0" spread="4.26"/>
                    <measurement group_id="O3" value="6.0" spread="6.45"/>
                    <measurement group_id="O4" value="2.9" spread="3.68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from Baseline Part 2 Week 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.1" spread="3.96"/>
                    <measurement group_id="O2" value="1.2" spread="3.00"/>
                    <measurement group_id="O3" value="0.5" spread="5.36"/>
                    <measurement group_id="O4" value="-0.4" spread="3.44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in the Blood Plasma Phenylalanine (Phe) Concentration at Part 4</title>
        <description>The long term effect of multiple dose levels of BMN165 on blood phe concentration in subjects who are administered BMN165 using pre-filled syringes.</description>
        <time_frame>At Part 4 week 57, 105, 161, 209 and 249</time_frame>
        <population>All Subjects Entered 165-302 Part 4 Data</population>
        <group_list>
          <group group_id="O1">
            <title>BMN165 &lt; 20 mg/Day - Part 4</title>
            <description>BMN165 &lt; 20 mg/day subcutaneous injection administered using a prefilled syringe in Part 4.</description>
          </group>
          <group group_id="O2">
            <title>BMN165 20 to &lt; 40 mg/Day - Part 4</title>
            <description>BMN165 &lt; 20 mg/day subcutaneous injection administered using a prefilled syringe in Part 4.</description>
          </group>
          <group group_id="O3">
            <title>BMN165 40 to &lt; 60 mg/Day - Part 4</title>
            <description>BMN165 40 to &lt; 60 mg/day subcutaneous injection administered using a prefilled syringe in Part 4.</description>
          </group>
          <group group_id="O4">
            <title>BMN165 &gt;= 60 mg/Day - Part 4</title>
            <description>BMN165 &gt;= 60 mg/day subcutaneous injection administered using a prefilled syringe in Part 4.</description>
          </group>
          <group group_id="O5">
            <title>BMN165 All Dose - Part 4</title>
            <description>Up to 60mg/day BMN165 subcutaneous injection administered using a prefilled syringe in Part 4.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in the Blood Plasma Phenylalanine (Phe) Concentration at Part 4</title>
          <description>The long term effect of multiple dose levels of BMN165 on blood phe concentration in subjects who are administered BMN165 using pre-filled syringes.</description>
          <population>All Subjects Entered 165-302 Part 4 Data</population>
          <units>µmol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="61"/>
                <count group_id="O2" value="131"/>
                <count group_id="O3" value="184"/>
                <count group_id="O4" value="62"/>
                <count group_id="O5" value="202"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Change from Baseline to Part 4 Week 57</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="20"/>
                    <count group_id="O2" value="36"/>
                    <count group_id="O3" value="91"/>
                    <count group_id="O4" value="33"/>
                    <count group_id="O5" value="180"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1004.9" spread="541.19"/>
                    <measurement group_id="O2" value="-984.0" spread="531.33"/>
                    <measurement group_id="O3" value="-810.2" spread="595.24"/>
                    <measurement group_id="O4" value="-662.3" spread="465.61"/>
                    <measurement group_id="O5" value="-839.5" spread="562.74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from Baseline to Part 4 Week 105</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="29"/>
                    <count group_id="O2" value="31"/>
                    <count group_id="O3" value="74"/>
                    <count group_id="O4" value="32"/>
                    <count group_id="O5" value="166"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1015.3" spread="557.00"/>
                    <measurement group_id="O2" value="-1109.2" spread="474.25"/>
                    <measurement group_id="O3" value="-858.5" spread="593.73"/>
                    <measurement group_id="O4" value="-641.0" spread="568.67"/>
                    <measurement group_id="O5" value="-890.8" spread="578.38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from Baseline to Part 4 Week 161</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="29"/>
                    <count group_id="O3" value="31"/>
                    <count group_id="O4" value="22"/>
                    <count group_id="O5" value="96"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1006.5" spread="514.76"/>
                    <measurement group_id="O2" value="-1111.9" spread="519.40"/>
                    <measurement group_id="O3" value="-662.8" spread="433.80"/>
                    <measurement group_id="O4" value="-808.6" spread="558.22"/>
                    <measurement group_id="O5" value="-882.0" spread="528.61"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from Baseline to Part 4 Week 209</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="8"/>
                    <count group_id="O2" value="5"/>
                    <count group_id="O3" value="8"/>
                    <count group_id="O4" value="9"/>
                    <count group_id="O5" value="30"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-897.3" spread="494.41"/>
                    <measurement group_id="O2" value="-1020.4" spread="495.79"/>
                    <measurement group_id="O3" value="-541.6" spread="245.83"/>
                    <measurement group_id="O4" value="-961.7" spread="339.92"/>
                    <measurement group_id="O5" value="-842.3" spread="418.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from Baseline to Part 4 Week 249</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="2"/>
                    <count group_id="O2" value="0"/>
                    <count group_id="O3" value="0"/>
                    <count group_id="O4" value="1"/>
                    <count group_id="O5" value="3"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1059.5" spread="160.51"/>
                    <measurement group_id="O4" value="-1314.0" spread="NA">Number of subjects participated in week 249 visit is one.</measurement>
                    <measurement group_id="O5" value="-1144.3" spread="185.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in the Cognitive and Mood Symptoms Measured by PKU POMS TMD at Part 2</title>
        <description>Phenylketonuria (PKU) Total Mood Disturbance (TMD) Profile of Mood States (POMS)&#xD;
PKU POMS TMD is self-rated, each item in the tool is rated using a five-point Likert scale: 0 (not at all), 1 (a little), 2 (moderately), 3 (quite a bit), and 4 (extremely).</description>
        <time_frame>At Part 2 baseline and change from baseline at Part 2 week 8</time_frame>
        <population>mITT population</population>
        <group_list>
          <group group_id="O1">
            <title>BMN165 20mg/Day</title>
            <description>BMN165 20mg/day subcutaneous injection administered using vial and syringe in Part 1, 2 and 3A.&#xD;
BMN165 20mg/day subcutaneous injection administered using a prefilled syringe in Part 3B.</description>
          </group>
          <group group_id="O2">
            <title>Placebo 20mg/Day</title>
            <description>Matching placebo 20mg/day subcutaneous injection administered using vial and syringe in Part 2.</description>
          </group>
          <group group_id="O3">
            <title>BMN165 40mg/Day</title>
            <description>BMN165 40mg/day subcutaneous injection administered using vial and syringe in Part 1, 2 and 3A.&#xD;
BMN165 40mg/day subcutaneous injection administered using a prefilled syringe in Part 3B.</description>
          </group>
          <group group_id="O4">
            <title>Placebo 40mg/Day</title>
            <description>Matching placebo 40mg/day subcutaneous injection administered using vial and syringe in Part 2.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in the Cognitive and Mood Symptoms Measured by PKU POMS TMD at Part 2</title>
          <description>Phenylketonuria (PKU) Total Mood Disturbance (TMD) Profile of Mood States (POMS)&#xD;
PKU POMS TMD is self-rated, each item in the tool is rated using a five-point Likert scale: 0 (not at all), 1 (a little), 2 (moderately), 3 (quite a bit), and 4 (extremely).</description>
          <population>mITT population</population>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="14"/>
                <count group_id="O3" value="29"/>
                <count group_id="O4" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.1" spread="14.18"/>
                    <measurement group_id="O2" value="8.6" spread="10.84"/>
                    <measurement group_id="O3" value="8.9" spread="12.28"/>
                    <measurement group_id="O4" value="5.0" spread="8.56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from Baseline Part 2 Week 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.8" spread="12.63"/>
                    <measurement group_id="O2" value="4.3" spread="11.96"/>
                    <measurement group_id="O3" value="-2.0" spread="10.25"/>
                    <measurement group_id="O4" value="0.0" spread="14.08"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in the Cognitive and Mood Symptoms Measured by PKU POMS Confusion Subscale at Part 2</title>
        <description>PKU POMS confusion mood domain (referred to as the confusion subscale) is self-rated, each item in the tool is rated using a five-point Likert scale: 0 (not at all), 1 (a little), 2 (moderately), 3 (quite a bit), and 4 (extremely).</description>
        <time_frame>At Part 2 baseline and change from baseline at Part 2 week 8</time_frame>
        <population>mITT population</population>
        <group_list>
          <group group_id="O1">
            <title>BMN165 20mg/Day</title>
            <description>BMN165 20mg/day subcutaneous injection administered using vial and syringe in Part 1, 2 and 3A.&#xD;
BMN165 20mg/day subcutaneous injection administered using a prefilled syringe in Part 3B.</description>
          </group>
          <group group_id="O2">
            <title>Placebo 20mg/Day</title>
            <description>Matching placebo 20mg/day subcutaneous injection administered using vial and syringe in Part 2.</description>
          </group>
          <group group_id="O3">
            <title>BMN165 40mg/Day</title>
            <description>BMN165 40mg/day subcutaneous injection administered using vial and syringe in Part 1, 2 and 3A.&#xD;
BMN165 40mg/day subcutaneous injection administered using a prefilled syringe in Part 3B.</description>
          </group>
          <group group_id="O4">
            <title>Placebo 40mg/Day</title>
            <description>Matching placebo 40mg/day subcutaneous injection administered using vial and syringe in Part 2.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in the Cognitive and Mood Symptoms Measured by PKU POMS Confusion Subscale at Part 2</title>
          <description>PKU POMS confusion mood domain (referred to as the confusion subscale) is self-rated, each item in the tool is rated using a five-point Likert scale: 0 (not at all), 1 (a little), 2 (moderately), 3 (quite a bit), and 4 (extremely).</description>
          <population>mITT population</population>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="14"/>
                <count group_id="O3" value="29"/>
                <count group_id="O4" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.0" spread="2.09"/>
                    <measurement group_id="O2" value="2.1" spread="1.49"/>
                    <measurement group_id="O3" value="2.4" spread="2.02"/>
                    <measurement group_id="O4" value="1.2" spread="1.53"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from Baseline Part 2 Week 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.8" spread="2.79"/>
                    <measurement group_id="O2" value="1.4" spread="2.47"/>
                    <measurement group_id="O3" value="-0.3" spread="1.84"/>
                    <measurement group_id="O4" value="0.5" spread="2.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change From Baseline in the Cognitive and Mood Symptoms Measured by POMS TMD at Part 2</title>
        <description>Full-length POMS TMD is self-rated, each item in the tool is rated using a five-point Likert scale: 0 (not at all), 1 (a little), 2 (moderately), 3 (quite a bit), and 4 (extremely).</description>
        <time_frame>At Part 2 baseline and change from baseline at Part 2 week 8</time_frame>
        <population>mITT population</population>
        <group_list>
          <group group_id="O1">
            <title>BMN165 20mg/Day</title>
            <description>BMN165 20mg/day subcutaneous injection administered using vial and syringe in Part 1, 2 and 3A.&#xD;
BMN165 20mg/day subcutaneous injection administered using a prefilled syringe in Part 3B.</description>
          </group>
          <group group_id="O2">
            <title>Placebo 20mg/Day</title>
            <description>Matching placebo 20mg/day subcutaneous injection administered using vial and syringe in Part 2.</description>
          </group>
          <group group_id="O3">
            <title>BMN165 40mg/Day</title>
            <description>BMN165 40mg/day subcutaneous injection administered using vial and syringe in Part 1, 2 and 3A.&#xD;
BMN165 40mg/day subcutaneous injection administered using a prefilled syringe in Part 3B.</description>
          </group>
          <group group_id="O4">
            <title>Placebo 40mg/Day</title>
            <description>Matching placebo 40mg/day subcutaneous injection administered using vial and syringe in Part 2.</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in the Cognitive and Mood Symptoms Measured by POMS TMD at Part 2</title>
          <description>Full-length POMS TMD is self-rated, each item in the tool is rated using a five-point Likert scale: 0 (not at all), 1 (a little), 2 (moderately), 3 (quite a bit), and 4 (extremely).</description>
          <population>mITT population</population>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="29"/>
                <count group_id="O2" value="14"/>
                <count group_id="O3" value="29"/>
                <count group_id="O4" value="14"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Baseline</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="16.2" spread="35.63"/>
                    <measurement group_id="O2" value="18.1" spread="28.26"/>
                    <measurement group_id="O3" value="24.3" spread="35.38"/>
                    <measurement group_id="O4" value="13.3" spread="21.63"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from Baseline Part 2 Week 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="13.1" spread="30.73"/>
                    <measurement group_id="O2" value="7.3" spread="26.23"/>
                    <measurement group_id="O3" value="-3.2" spread="26.63"/>
                    <measurement group_id="O4" value="-1.7" spread="29.34"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Up to 301 weeks</time_frame>
      <desc>Safety Analyses consists of the population for safety analyses of all subjects who enrolled into the study and all subjects who enrolled into each study part for analysis by study part.</desc>
      <group_list>
        <group group_id="E1">
          <title>Part 1 - 20 mg/Day</title>
          <description>BMN165 20mg/day subcutaneous injection administered using vial and syringe.</description>
        </group>
        <group group_id="E2">
          <title>Part 1 - 40 mg/Day</title>
          <description>BMN165 40mg/day subcutaneous injection administered using vial and syringe.</description>
        </group>
        <group group_id="E3">
          <title>Part 2 - 20 mg/Day Active</title>
          <description>BMN165 20mg/day subcutaneous injection administered using vial and syringe.</description>
        </group>
        <group group_id="E4">
          <title>Part 2 - 40 mg/Day Active</title>
          <description>BMN165 40mg/day subcutaneous injection administered using vial and syringe.</description>
        </group>
        <group group_id="E5">
          <title>Part 2 - 20 mg/Day Placebo</title>
          <description>Matching placebo 20mg/day subcutaneous injection administered using vial and syringe.</description>
        </group>
        <group group_id="E6">
          <title>Part 2 - 40 mg/Day Placebo</title>
          <description>Matching placebo 40mg/day subcutaneous injection administered using vial and syringe.</description>
        </group>
        <group group_id="E7">
          <title>Part 3 - Stay on Active 20 mg/Day</title>
          <description>BMN165 20mg/day subcutaneous injection administered using vial and syringe in Part 3A.&#xD;
BMN165 20mg/day subcutaneous injection administered using a prefilled syringe in Part 3B.</description>
        </group>
        <group group_id="E8">
          <title>Part 3 - Stay on Active 40 mg/Day</title>
          <description>BMN165 40mg/day subcutaneous injection administered using vial and syringe in Part 3A.&#xD;
BMN165 40mg/day subcutaneous injection administered using a prefilled syringe in Part 3B.</description>
        </group>
        <group group_id="E9">
          <title>Part 3 - Switch From Placebo to Active 20 mg/Day</title>
          <description>BMN165 20mg/day subcutaneous injection administered using vial and syringe in Part 3A.&#xD;
BMN165 20mg/day subcutaneous injection administered using a prefilled syringe in Part 3B.</description>
        </group>
        <group group_id="E10">
          <title>Part 3 - Switch From Placebo to Active 40 mg/Day</title>
          <description>BMN165 40mg/day subcutaneous injection administered using vial and syringe in Part 3A.&#xD;
BMN165 40mg/day subcutaneous injection administered using a prefilled syringe in Part 3B.</description>
        </group>
        <group group_id="E11">
          <title>Part 4 - &lt; 20 mg/Day</title>
          <description>BMN165 &lt;20mg/day subcutaneous injection administered using a prefilled syringe.</description>
        </group>
        <group group_id="E12">
          <title>Part 4 - 20 to &lt; 40 mg/Day</title>
          <description>BMN165 20 to &lt;40mg/day subcutaneous injection administered using a prefilled syringe.</description>
        </group>
        <group group_id="E13">
          <title>Part 4 - 40 to &lt; 60 mg/Day</title>
          <description>BMN165 40 to &lt;60mg/day subcutaneous injection administered using a prefilled syringe.</description>
        </group>
        <group group_id="E14">
          <title>Part 4 - &gt;= 60 mg/Day</title>
          <description>BMN165 &gt;=60mg/day subcutaneous injection administered using a prefilled syringe.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA 18.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="7" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="6" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="16" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="5" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Iron Deficiency Anaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Lymphoid Tissue Hyperplasia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Epiploic Appendagitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Haemorrhoidal Haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Haemorrhoids</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Chest Pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Non-cardiac Chest Pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Anaphylactic Reaction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="4" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Anaphylactoid Reaction</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Appendicitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Diverticulitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Soft Tissue Infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Road Traffic Accident</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Post procedural haematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Tendon injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Blood creatine phosphokinase increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Blood pressure increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Scoliosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Appendix Adenoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Xanthogranuloma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Loss of consciousness</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Migraine</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Presyncope</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Pregnancy, puerperium and perinatal conditions</title>
            <event_list>
              <event>
                <sub_title>Abortion missed</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Gestational hypertension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Hyperemesis gravidarum</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Agitation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Brief Psychotic Disorder with Marked Stressors</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Parasomnia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Endometriosis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Angioedema</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Skin Exfoliation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>MedDRA 18.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="70" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="59" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="27" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="28" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="14" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="13" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="19" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="15" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="8" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="7" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="62" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="105" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="178" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="59" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Lymphadenopathy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="8" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="18" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="3" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Ear pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="3" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="4" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Tinnitus</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Vertigo</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="3" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="3" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Blepharospasm</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="8" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="18" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="34" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="13" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="3" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="10" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="11" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="28" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="16" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Diarrhoea</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="8" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="15" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="25" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="9" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="7" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="5" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="17" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="4" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="3" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="10" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="10" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="5" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="4" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="7" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="10" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="6" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Toothache</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="4" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="6" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="12" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="5" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Gastrooesophageal reflux disease</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="3" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="6" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="8" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="9" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="3" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="10" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="6" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Abdominal discomfort</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="3" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="11" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Frequent bowel movements</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Abdominal distension</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="5" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Injection site reaction</sub_title>
                <counts group_id="E1" subjects_affected="13" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="6" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="14" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="46" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="11" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Injection site bruising</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="5" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="14" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="41" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="12" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Injection site pruritus</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="3" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="9" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="24" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="10" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Fatigue</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="5" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="4" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="10" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="8" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="14" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="10" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Injection site induration</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="4" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="14" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="24" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="6" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Injection site pain</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="3" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="10" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="22" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="9" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Injection site swelling</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="4" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="9" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="19" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="3" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Injection site erythema</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="3" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="3" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="19" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="7" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="4" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="4" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="19" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="6" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Peripheral swelling</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="3" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="4" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="15" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="5" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="10" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="5" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Injection site mass</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="12" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="4" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="10" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Injection site haemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="3" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="5" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="5" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="5" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Chest discomfort</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Feeling abnormal</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Inflammation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="6" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Malaise</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Seasonal allergy</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="8" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="6" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="19" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="3" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Hypersensitivity</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="3" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="10" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="15" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="27" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="59" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="19" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="14" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="29" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="51" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="10" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="9" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="13" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="22" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="11" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="3" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="5" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="15" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="8" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="3" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="9" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="13" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="3" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Gastroenteritis viral</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="5" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="7" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="11" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="7" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="3" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="5" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="13" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="3" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Pharyngitis streptococcal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="3" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="10" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="4" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Ear infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="3" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="4" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="6" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="3" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Viral infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="3" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="10" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="4" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="6" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Conjunctivitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="4" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="6" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Fungal infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="3" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="3" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Fungal skin infection</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Laryngitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="3" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Labyrinthitis</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Vaginal infection</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Contusion</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="2" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="9" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="9" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="22" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="5" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Arthropod bite</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="3" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="12" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="4" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Ligament sprain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="5" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="7" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="5" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Muscle strain</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="8" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Post-traumatic pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Road traffic accident</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Skin abrasion</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Injury</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Amino acid level decreased</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="9" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="13" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="37" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="13" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Blood creatine phosphokinase increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="6" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Complement factor C3 decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="5" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Blood bilirubin increased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Weight decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Weight increased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Blood cortisol decreased</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="3" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Complement factor decreased</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthralgia</sub_title>
                <counts group_id="E1" subjects_affected="9" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="7" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="3" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="3" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="2" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="16" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="33" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="64" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="22" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="10" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="14" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="33" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="7" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="9" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="14" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="24" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="10" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Musculoskeletal pain</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="4" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="6" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="16" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="3" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Myalgia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="4" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="5" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="15" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Neck pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="5" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="12" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="5" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Muscle spasms</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="3" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="3" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="8" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="5" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Flank pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="12" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="6" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="4" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="3" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="20" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="29" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="59" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="24" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="10" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="6" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="21" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="11" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Migraine</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="6" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="8" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="18" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="9" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Disturbance in attention</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="3" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="5" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="3" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Lethargy</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="8" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Memory impairment</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="4" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Tremor</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="4" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="4" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Dyspraxia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Sciatica</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Hyperreflexia</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="4" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="5" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Somnolence</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Presyncope</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Anxiety</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="4" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="11" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="10" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="23" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="6" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Depression</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="9" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="11" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="13" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="3" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Insomnia</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="6" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="7" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="17" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Irritability</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Agitation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Depressive symptom</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Mood altered</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Distractibility</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Emotional disorder</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Stress</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="1" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="2" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Ketonuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Proteinuria</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="3" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Urine odour abnormal</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="0" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Dysmenorrhoea</sub_title>
                <counts group_id="E1" subjects_affected="5" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="3" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="4" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="9" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="3" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="2" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="6" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="20" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="29" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="10" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Oropharyngeal pain</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="6" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="14" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="32" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="8" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Nasal congestion</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="3" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="9" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="12" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="20" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="8" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Sinus congestion</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="7" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="5" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="12" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="4" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Rhinorrhoea</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="7" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="3" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Wheezing</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="2" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="1" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Rash</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="3" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="1" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="2" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="2" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="7" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="8" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="34" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="14" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Pruritus</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="6" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="13" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="33" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="14" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Urticaria</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="1" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="4" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="12" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="28" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="12" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Alopecia</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="2" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="2" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="5" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="12" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="12" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="6" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Erythema</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="1" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="5" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="6" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="9" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="4" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Pruritus generalised</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="2" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="8" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="4" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Dry skin</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="6" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Papule</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="1" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="2" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="4" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Rash maculo-papular</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="0" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="1" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="1" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="3" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
              <event>
                <sub_title>Skin exfoliation</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="86"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="78"/>
                <counts group_id="E3" subjects_affected="1" subjects_at_risk="34"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E7" subjects_affected="0" subjects_at_risk="23"/>
                <counts group_id="E8" subjects_affected="1" subjects_at_risk="18"/>
                <counts group_id="E9" subjects_affected="0" subjects_at_risk="11"/>
                <counts group_id="E10" subjects_affected="0" subjects_at_risk="8"/>
                <counts group_id="E11" subjects_affected="0" subjects_at_risk="67"/>
                <counts group_id="E12" subjects_affected="0" subjects_at_risk="152"/>
                <counts group_id="E13" subjects_affected="1" subjects_at_risk="186"/>
                <counts group_id="E14" subjects_affected="0" subjects_at_risk="89"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Debra Lounsbury/Sr Principle Scientist, Clinical Sciences</name_or_title>
      <organization>BioMarin Pharmaceutical Inc</organization>
      <phone>415-506-6348</phone>
      <email>Dlounsbury@bmrn.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

